ABC Communications

• ABC Comments to the FDA on Draft Guidance for Industry "Diversity Plans to Improve Enrollment of Participants from Underrepresented Racial and Ethnic Populations in Clinical Trials”June 13, 2022
• Organizational Letter to Energy & Commerce Committee in “Support of the NIH Clinical Trial Diversity Act”June 9, 2022
• ABC Letter to Rep. Eshoo on the “Diverse and Equitable Participation in Clinical Trials (DEPICT) Act”July 19, 2021

Resources

• Rep. Robin Kelly Press Release on Introduction of the “NIH Clinical Trial Diversity Act” with ABC Endorsement and Quote from Dr. Michelle Albert May 19, 2022
• NIH Clinical Trial Diversity Act of 2022 (H.R. 7845) ✓ABC Endorsed
• Rep. Anna Eshoo Press Release on Committee Consideration of the “Diverse and Equitable Participation in Clinical Trails (DEPICT) Act” May 18, 2022

Rep. Anna Eshoo Press Statement on New FDA Guidance for Diversity in Clinical Trials April 13, 2022

• FDA Draft Guidance: Diversity Plans to Improve Enrollment of Participants from Underrepresented Racial and Ethnic Populations in Clinical Trials Guidance for Industry April 13, 2022
• Reps. Anna Eshoo, Brian Fitzpatrick and Robin Kelly Press Release on Introduction of the “Diverse and Equitable Participation in Clinical Trials (DEPICT) Act”  February 3, 2022
• Diverse and Equity Participation in Clinical Trials (DEPICT) Act ✓ABC Endorsed